Abstract:Resveratrol(RES),a non-flavonoid polyphenol extracted from a wide variety of plants,exhibits neuroprotective activities against Parkinson's disease(PD).However,undesirable water solubility of RES reduces its oral bioavailability and demonstrates low efficacy in blood and brain,thus limiting its application.In present study,a nanocrystal formulation of RES(RES-NCs)was developed to enhance its oral bioavailability and delivery into brain for PD treatment.RES-NCs were fabricated with hydroxypropyl methylcellulose(HPMC)stabilizer via antisolvent precipitation approach.The obtained RES-NCs displayed the particle size of 222.54±1.66 nm,the PDI of 0.125±0.035,the zeta potential of-9.41±0.37 mV,and a rapid in vitro dissolution rate.Molecular dynamics simulation of RES and HPMC revealed an interaction energy of-68.09 kJ/mol and a binding energy of-30.98±0.388 kJ/mol,indicating that the spontaneous binding between the two molecules is through van der Waals forces.RES-NCs conferred enhanced cellular uptake as well as improved permeability relative to pure RES.In addition,RES-NCs were able to protect neurons against cytotoxicity induced by MPP+.Meanwhile,RES-NCs exerted no significant toxic effects on zebrafish embryos and larvae,and did not influence their survival and hatching rates.When orally administered to rats,RES-NCs exhibited more favorable pharmacokinetics than pure RES,with higher plasma and brain concentrations.More importantly,MPTP-induced PD mice showed notable improvements in behavior,attenuated dopamine deficiency,and elevated levels of dopamine and its metabolites after the treatment with RES-NCs.Furthermore,immunoblot analysis revealed that the neuroprotective role of RES-NCs may be at least partially mediated by Akt/Gsk3β signaling pathway.Taken altogether,RES-NCs can serve as a potential treatment modality for PD,offering means of improving RES oral bioavailability and brain accumulation.

Synthesis and bioactivity evaluation of glycosylated resveratrol derivatives as antioxidative neuroprotection agents against cerebral Ischemia-Reperfusion injury

Synthesis and Evaluation of Glycosylated Quercetin to Enhance Neuroprotective Effects on Cerebral Ischemia-Reperfusion

Development of a brain-targeted nano drug delivery system to enhance the treatment of neurodegenerative effects of resveratrol

Resveratrol-Loaded Copolymer Nanoparticles with Anti-neurological Impairment, Antioxidant and Anti-inflammatory Activities against Cerebral Ischemia-Reperfusion Injury

Synthesis of Novel EGCG-glucose Conjugates and Studies of Their Antioxidative Properties for Neuroprotections

Design, Synthesis, And Evaluation Of Resveratrol Derivatives As A Beta(1-42) Aggregation Inhibitors, Antioxidants, And Neuroprotective Agents

Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease.

Design, Synthesis and Biological Evaluation of Tricyclic Diterpene Derivatives As Novel Neuroprotective Agents Against Ischemic Brain Injury.

Resveratrol Treatment in Different Time-Attenuated Neuronal Apoptosis after Oxygen and Glucose Deprivation/Reoxygenation Via Enhancing the Activation of Nrf-2 Signaling Pathway in Vitro

Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.

Design, Synthesis, and Biological Evaluation of Novel Tetramethylpyrazine- Nitrone Derivatives As Antioxidants

Design, synthesis and evaluation of antioxidant and anti-inflammatory activities of novel resveratrol derivatives as potential multifunctional drugs

Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.

The Synergistic Neuroprotective Effects of Combined Rosuvastatin and Resveratrol Pretreatment Against Cerebral Ischemia/Reperfusion Injury

Synthesis Of Resveratrol Analogues, And Evaluation Of Their Cytotoxic And Xanthine Oxidase Inhibitory Activities

Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β-amyloid through activation of SIRT1/Akt1 pathway.

Enhancement of Oral Bioavailability and Anti-Parkinsonian Efficacy of Resveratrol Through a Nanocrystal Formulation

Synthesis and Neuroprotective Effect of E-3,4-dihydroxy Styryl Aralkyl Ketones Derivatives Against Oxidative Stress and Inflammation.

Design, Synthesis and Biological Evaluation of Novel (e)‐hydroxystyryl Aralkyl Sulfones As Neuroprotective Agents

Design, Synthesis and Pharmacological Evaluation of (E)-3,4-dihydroxy Styryl Sulfonamides Derivatives As Multifunctional Neuroprotective Agents Against Oxidative and Inflammatory Injury.

Synthesis and biological evaluation of aryloxyacetamide derivatives as neuroprotective agents.